Advertisement
CSTL vs NEO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Buy and NEO is a Hold.
Aroon Indicator for CSTL shows an upward move is likely
CSTL's Aroon Indicator triggered a bullish signal on October 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 227 similar instances where the Aroon Indicator showed a similar pattern. In 207 of the 227 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on CSTL as a result. In 74 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for CSTL just turned positive on October 27, 2026. Looking at past instances where CSTL's MACD turned positive, the stock continued to rise in 25 of 37 cases over the following month. The odds of a continued upward trend are 68%.
CSTL moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +11.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where CSTL advanced for three days, in 231 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for CSTL crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CSTL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
CSTL broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.503) is normal, around the industry mean (66.893). P/E Ratio (-60.172) is within average values for comparable stocks, (2.527). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.947) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. CSTL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSTL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
Momentum Indicator for NEO turns positive, indicating new upward trend
NEO saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 71 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for NEO just turned positive on October 27, 2026. Looking at past instances where NEO's MACD turned positive, the stock continued to rise in 36 of 48 cases over the following month. The odds of a continued upward trend are 75%.
NEO moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +7.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where NEO advanced for three days, in 215 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 155 of 189 cases where NEO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for NEO crossed bearishly below the 50-day moving average on October 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
NEO broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.932) is normal, around the industry mean (66.893). P/E Ratio (-45.974) is within average values for comparable stocks, (2.527). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.189) is also within normal values, averaging (9.775).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. NEO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
CSTL | NEO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 43 | 23 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 20 Undervalued | 27 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 92 | |
PRICE GROWTH RATING 1..100 | 37 | 37 | |
P/E GROWTH RATING 1..100 | 93 | 74 | |
SEASONALITY SCORE 1..100 | 50 | 43 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CSTL's Valuation (20) in the null industry is in the same range as NEO (27) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.
CSTL's Profit vs Risk Rating (100) in the null industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.
CSTL's SMR Rating (92) in the null industry is in the same range as NEO (92) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.
CSTL's Price Growth Rating (37) in the null industry is in the same range as NEO (37) in the Medical Or Nursing Services industry. This means that CSTL’s stock grew similarly to NEO’s over the last 12 months.
NEO's P/E Growth Rating (74) in the Medical Or Nursing Services industry is in the same range as CSTL (93) in the null industry. This means that NEO’s stock grew similarly to CSTL’s over the last 12 months.
| CSTL | NEO | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | N/A |
| Stochastic ODDS (%) | 1 day ago 74% | 1 day ago 84% |
| Momentum ODDS (%) | 1 day ago 82% | 1 day ago 83% |
| MACD ODDS (%) | 1 day ago 68% | 1 day ago 75% |
| TrendWeek ODDS (%) | 1 day ago 83% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 81% | 1 day ago 84% |
| Advances ODDS (%) | 1 day ago 78% | 2 days ago 78% |
| Declines ODDS (%) | 7 days ago 79% | 11 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 76% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 82% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CSTL’s FA Score shows that 1 FA rating(s) are green while NEO’s FA Score has 1 green FA rating(s).
- CSTL’s FA Score: 1 green, 4 red.
- NEO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CSTL’s TA Score shows that 5 TA indicator(s) are bullish while NEO’s TA Score has 5 bullish TA indicator(s).
- CSTL’s TA Score: 5 bullish, 5 bearish.
- NEO’s TA Score: 5 bullish, 4 bearish.
Price Growth
CSTL (@Medical Specialties) experienced а +16.03% price change this week, while NEO (@Medical Specialties) price change was +9.40% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +4.55%. For the same industry, the average monthly price growth was -2.42%, and the average quarterly price growth was +52.72%.
Reported Earning Dates
CSTL is expected to report earnings on Nov 05, 2026.
NEO is expected to report earnings on Feb 23, 2027.
Industries' Descriptions
@Medical Specialties (+4.55% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
CSTL and
Correlation & Price change
A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with TCMD. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then TCMD could also see price increases.
| Ticker / NAME | Correlation To CSTL | 1D Price Change % | ||
|---|---|---|---|---|
| CSTL | 100% | +4.99% | ||
| TCMD - CSTL | 50% Loosely correlated | +1.67% | ||
| NEO - CSTL | 48% Loosely correlated | -0.33% | ||
| GH - CSTL | 44% Loosely correlated | +1.49% | ||
| ADPT - CSTL | 44% Loosely correlated | -0.70% | ||
| NTRA - CSTL | 41% Loosely correlated | +2.73% | ||
More | ||||
NEO and
Correlation & Price change
A.I.dvisor indicates that over the last year, NEO has been loosely correlated with NTRA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then NTRA could also see price increases.
| Ticker / NAME | Correlation To NEO | 1D Price Change % | ||
|---|---|---|---|---|
| NEO | 100% | -0.33% | ||
| NTRA - NEO | 54% Loosely correlated | +2.73% | ||
| ADPT - NEO | 52% Loosely correlated | -0.70% | ||
| CSTL - NEO | 47% Loosely correlated | +4.99% | ||
| RVTY - NEO | 46% Loosely correlated | +0.27% | ||
| SHC - NEO | 44% Loosely correlated | +0.27% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SFGV | 36.21 | 0.24 | +0.65% |
| Sequoia Global Value ETF (SFGV) | |||
| IFGL | 20.90 | 0.09 | +0.44% |
| iShares International Developed Real Estate ETF (IFGL) | |||
| BSMU | 21.41 | N/A | +0.02% |
| Invesco BulletShares 2030 Municipal Bond ETF (BSMU) | |||
| TECY | 19.98 | N/A | N/A |
| GraniteShares YieldBOOST Technology ETF (TECY) | |||
| DLAG | 33.93 | -0.03 | -0.09% |
| FT Vest U.S. Equity Dual Directional Buffer ETF - August (DLAG) | |||